These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 24653673)
41. Prostaglandin A1 Decreases the Phosphorylation of Tau by Activating Protein Phosphatase 2A via a Michael Addition Mechanism at Cysteine 377. Xu GB; Guan PP; Wang P Mol Neurobiol; 2021 Mar; 58(3):1114-1127. PubMed ID: 33095414 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. Planel E; Yasutake K; Fujita SC; Ishiguro K J Biol Chem; 2001 Sep; 276(36):34298-306. PubMed ID: 11441005 [TBL] [Abstract][Full Text] [Related]
43. Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus. Zhang CE; Tian Q; Wei W; Peng JH; Liu GP; Zhou XW; Wang Q; Wang DW; Wang JZ Neurobiol Aging; 2008 Nov; 29(11):1654-65. PubMed ID: 17537547 [TBL] [Abstract][Full Text] [Related]
44. Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau Miao J; Shi R; Li L; Chen F; Zhou Y; Tung YC; Hu W; Gong CX; Iqbal K; Liu F Front Aging Neurosci; 2019; 11():34. PubMed ID: 30890929 [TBL] [Abstract][Full Text] [Related]
45. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta. Qian W; Shi J; Yin X; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F J Alzheimers Dis; 2010; 19(4):1221-9. PubMed ID: 20308788 [TBL] [Abstract][Full Text] [Related]
46. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Kickstein E; Krauss S; Thornhill P; Rutschow D; Zeller R; Sharkey J; Williamson R; Fuchs M; Köhler A; Glossmann H; Schneider R; Sutherland C; Schweiger S Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21830-5. PubMed ID: 21098287 [TBL] [Abstract][Full Text] [Related]
47. Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies. Sontag E; Nunbhakdi-Craig V; Lee G; Brandt R; Kamibayashi C; Kuret J; White CL; Mumby MC; Bloom GS J Biol Chem; 1999 Sep; 274(36):25490-8. PubMed ID: 10464280 [TBL] [Abstract][Full Text] [Related]
48. DHCR24 Knockdown Lead to Hyperphosphorylation of Tau at Thr181, Thr231, Ser262, Ser396, and Ser422 Sites by Membrane Lipid-Raft Dependent PP2A Signaling in SH-SY5Y Cells. Qi Z; Zhang Y; Yao K; Zhang M; Xu Y; Zhang J; Bai X; Zu H Neurochem Res; 2021 Jul; 46(7):1627-1640. PubMed ID: 33710538 [TBL] [Abstract][Full Text] [Related]
49. Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology. Liu R; Zhou XW; Tanila H; Bjorkdahl C; Wang JZ; Guan ZZ; Cao Y; Gustafsson JA; Winblad B; Pei JJ J Cell Mol Med; 2008; 12(1):241-57. PubMed ID: 18208556 [TBL] [Abstract][Full Text] [Related]
50. Nmnat2 attenuates Tau phosphorylation through activation of PP2A. Cheng XS; Zhao KP; Jiang X; Du LL; Li XH; Ma ZW; Yao J; Luo Y; Duan DX; Wang JZ; Zhou XW J Alzheimers Dis; 2013; 36(1):185-95. PubMed ID: 23579329 [TBL] [Abstract][Full Text] [Related]
51. Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology. Gratuze M; Julien J; Petry FR; Morin F; Planel E Sci Rep; 2017 Apr; 7():46359. PubMed ID: 28402338 [TBL] [Abstract][Full Text] [Related]
52. Knockdown of phosphotyrosyl phosphatase activator induces apoptosis via mitochondrial pathway and the attenuation by simultaneous tau hyperphosphorylation. Luo DJ; Feng Q; Wang ZH; Sun DS; Wang Q; Wang JZ; Liu GP J Neurochem; 2014 Sep; 130(6):816-25. PubMed ID: 24821282 [TBL] [Abstract][Full Text] [Related]
53. How it all started: tau and protein phosphatase 2A. Liu C; Götz J J Alzheimers Dis; 2013; 37(3):483-94. PubMed ID: 23948891 [TBL] [Abstract][Full Text] [Related]
55. GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner. Chu D; Tan J; Xie S; Jin N; Yin X; Gong CX; Iqbal K; Liu F J Alzheimers Dis; 2016; 49(2):365-75. PubMed ID: 26484916 [TBL] [Abstract][Full Text] [Related]
56. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease. Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125 [TBL] [Abstract][Full Text] [Related]
57. Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes. Adams DG; Coffee RL; Zhang H; Pelech S; Strack S; Wadzinski BE J Biol Chem; 2005 Dec; 280(52):42644-54. PubMed ID: 16239230 [TBL] [Abstract][Full Text] [Related]
58. Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: a novel tool for Alzheimer's disease therapeutic application. Kamat PK; Rai S; Swarnkar S; Shukla R; Nath C Mol Neurobiol; 2014 Dec; 50(3):852-65. PubMed ID: 24710687 [TBL] [Abstract][Full Text] [Related]
59. Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer's Disease. Vafai SB; Stock JB FEBS Lett; 2002 May; 518(1-3):1-4. PubMed ID: 11997007 [TBL] [Abstract][Full Text] [Related]
60. Mice lacking phosphatase PP2A subunit PR61/B'delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta. Louis JV; Martens E; Borghgraef P; Lambrecht C; Sents W; Longin S; Zwaenepoel K; Pijnenborg R; Landrieu I; Lippens G; Ledermann B; Götz J; Van Leuven F; Goris J; Janssens V Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6957-62. PubMed ID: 21482799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]